- Home
- GNPX vs MARPS Comparison
GNPX vs MARPS Comparison
Compare GNPX & MARPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNPX
- MARPS
- Stock Information
- Founded
- GNPX 2009
- MARPS 1956
- Country
- GNPX United States
- MARPS United States
- Employees
- GNPX N/A
- MARPS N/A
- Industry
- GNPX Biotechnology: Pharmaceutical Preparations
- MARPS Oil & Gas Production
- Sector
- GNPX Health Care
- MARPS Energy
- Exchange
- GNPX Nasdaq
- MARPS Nasdaq
- Market Cap
- GNPX 7.4M
- MARPS 8.6M
- IPO Year
- GNPX 2018
- MARPS N/A
- Fundamental
- Price
- GNPX $0.17
- MARPS $4.66
- Analyst Decision
- GNPX
- MARPS
- Analyst Count
- GNPX 0
- MARPS 0
- Target Price
- GNPX N/A
- MARPS N/A
- AVG Volume (30 Days)
- GNPX 6.3M
- MARPS 12.7K
- Earning Date
- GNPX 08-14-2025
- MARPS 01-01-0001
- Dividend Yield
- GNPX N/A
- MARPS 8.07%
- EPS Growth
- GNPX N/A
- MARPS N/A
- EPS
- GNPX N/A
- MARPS 0.36
- Revenue
- GNPX N/A
- MARPS $1,036,019.00
- Revenue This Year
- GNPX N/A
- MARPS N/A
- Revenue Next Year
- GNPX N/A
- MARPS N/A
- P/E Ratio
- GNPX N/A
- MARPS $11.55
- Revenue Growth
- GNPX N/A
- MARPS N/A
- 52 Week Low
- GNPX $0.14
- MARPS $3.34
- 52 Week High
- GNPX $3.97
- MARPS $7.90
- Technical
- Relative Strength Index (RSI)
- GNPX 35.07
- MARPS 54.98
- Support Level
- GNPX $0.14
- MARPS $4.20
- Resistance Level
- GNPX $0.25
- MARPS $4.57
- Average True Range (ATR)
- GNPX 0.02
- MARPS 0.21
- MACD
- GNPX -0.01
- MARPS 0.01
- Stochastic Oscillator
- GNPX 23.78
- MARPS 100.00
About GNPX Genprex Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.
About MARPS Marine Petroleum Trust Units of Beneficial Interest
Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.